Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ovarian Neoplasms | 10 | 2016 | 312 | 1.090 |
Why?
|
DNA Transposable Elements | 6 | 2011 | 48 | 1.000 |
Why?
|
Retroelements | 7 | 2010 | 13 | 0.830 |
Why?
|
Gene Expression Profiling | 10 | 2016 | 626 | 0.550 |
Why?
|
Evolution, Molecular | 7 | 2010 | 268 | 0.540 |
Why?
|
Terminal Repeat Sequences | 4 | 2010 | 8 | 0.430 |
Why?
|
Neoplastic Stem Cells | 2 | 2011 | 78 | 0.430 |
Why?
|
Ovary | 2 | 2009 | 108 | 0.400 |
Why?
|
Repressor Proteins | 3 | 2019 | 249 | 0.390 |
Why?
|
Drosophila melanogaster | 2 | 2004 | 180 | 0.390 |
Why?
|
Prostatic Neoplasms | 5 | 2023 | 935 | 0.380 |
Why?
|
Open Reading Frames | 3 | 2007 | 77 | 0.380 |
Why?
|
DNA-Binding Proteins | 4 | 2017 | 539 | 0.370 |
Why?
|
Multipotent Stem Cells | 1 | 2009 | 16 | 0.360 |
Why?
|
Chromatin | 2 | 2011 | 169 | 0.310 |
Why?
|
Promoter Regions, Genetic | 3 | 2019 | 515 | 0.300 |
Why?
|
Epithelial Cells | 2 | 2011 | 384 | 0.300 |
Why?
|
Paired Box Transcription Factors | 1 | 2006 | 7 | 0.290 |
Why?
|
Fallopian Tubes | 1 | 2006 | 17 | 0.290 |
Why?
|
Transcription Factors | 5 | 2019 | 681 | 0.280 |
Why?
|
Phylogeny | 9 | 2010 | 644 | 0.270 |
Why?
|
Computational Biology | 3 | 2006 | 293 | 0.260 |
Why?
|
Cell Line, Tumor | 12 | 2023 | 2231 | 0.260 |
Why?
|
Gene Expression Regulation, Neoplastic | 8 | 2019 | 807 | 0.250 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2019 | 54 | 0.250 |
Why?
|
Coat Protein Complex I | 1 | 2004 | 1 | 0.240 |
Why?
|
COP-Coated Vesicles | 1 | 2004 | 1 | 0.240 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2004 | 58 | 0.240 |
Why?
|
DNA Helicases | 1 | 2004 | 41 | 0.230 |
Why?
|
DNA Polymerase II | 1 | 2003 | 4 | 0.230 |
Why?
|
Genome | 2 | 2007 | 125 | 0.230 |
Why?
|
Schizosaccharomyces | 1 | 2003 | 14 | 0.230 |
Why?
|
Genome, Fungal | 1 | 2003 | 22 | 0.230 |
Why?
|
Adenosine Triphosphatases | 1 | 2004 | 82 | 0.230 |
Why?
|
Histone Deacetylases | 1 | 2004 | 56 | 0.230 |
Why?
|
Nicardipine | 1 | 2023 | 10 | 0.230 |
Why?
|
Cell Proliferation | 5 | 2019 | 1198 | 0.220 |
Why?
|
Sequence Analysis, DNA | 2 | 2010 | 474 | 0.220 |
Why?
|
Protein Transport | 1 | 2004 | 302 | 0.220 |
Why?
|
Caenorhabditis elegans | 2 | 2002 | 78 | 0.220 |
Why?
|
Animals | 18 | 2023 | 15081 | 0.210 |
Why?
|
Humans | 31 | 2023 | 37093 | 0.210 |
Why?
|
Eukaryotic Cells | 1 | 2002 | 36 | 0.210 |
Why?
|
Membrane Proteins | 2 | 2016 | 517 | 0.210 |
Why?
|
Internet | 1 | 2004 | 211 | 0.210 |
Why?
|
Software | 1 | 2004 | 217 | 0.210 |
Why?
|
Cathepsin L | 2 | 2019 | 15 | 0.200 |
Why?
|
Adenocarcinoma | 2 | 2014 | 251 | 0.200 |
Why?
|
Molecular Sequence Data | 7 | 2009 | 1568 | 0.200 |
Why?
|
Euchromatin | 1 | 2001 | 6 | 0.200 |
Why?
|
Cell Cycle | 4 | 2019 | 326 | 0.200 |
Why?
|
Genome, Human | 3 | 2011 | 135 | 0.190 |
Why?
|
Amino Acid Sequence | 5 | 2004 | 1180 | 0.180 |
Why?
|
Systems Biology | 2 | 2011 | 22 | 0.180 |
Why?
|
Retroviridae | 1 | 1999 | 22 | 0.180 |
Why?
|
CCAAT-Binding Factor | 1 | 2019 | 2 | 0.170 |
Why?
|
Neoplasm Proteins | 2 | 2016 | 213 | 0.170 |
Why?
|
Repetitive Sequences, Nucleic Acid | 3 | 2007 | 31 | 0.170 |
Why?
|
Peroxidase | 1 | 2019 | 49 | 0.170 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2019 | 26 | 0.170 |
Why?
|
Extracellular Matrix Proteins | 1 | 2019 | 67 | 0.170 |
Why?
|
Neoplasms, Glandular and Epithelial | 2 | 2016 | 40 | 0.160 |
Why?
|
Vitis | 1 | 2019 | 31 | 0.160 |
Why?
|
Estrogen Receptor alpha | 1 | 2019 | 111 | 0.160 |
Why?
|
Homeodomain Proteins | 1 | 2019 | 132 | 0.160 |
Why?
|
Centrosome | 2 | 2015 | 28 | 0.160 |
Why?
|
Tumor Suppressor Proteins | 2 | 2017 | 194 | 0.160 |
Why?
|
DNA Methylation | 3 | 2007 | 325 | 0.150 |
Why?
|
Genitalia | 1 | 2017 | 17 | 0.150 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2017 | 33 | 0.150 |
Why?
|
Transfection | 3 | 2015 | 523 | 0.140 |
Why?
|
Chlamydia trachomatis | 1 | 2017 | 68 | 0.140 |
Why?
|
Dendritic Cells | 1 | 2017 | 113 | 0.140 |
Why?
|
Female | 15 | 2018 | 20969 | 0.140 |
Why?
|
Endogenous Retroviruses | 2 | 2006 | 16 | 0.140 |
Why?
|
Gene Regulatory Networks | 3 | 2016 | 120 | 0.140 |
Why?
|
Genes, Tumor Suppressor | 1 | 2016 | 63 | 0.130 |
Why?
|
Plant Extracts | 1 | 2019 | 286 | 0.130 |
Why?
|
Chlamydia Infections | 1 | 2017 | 196 | 0.130 |
Why?
|
Inhibitor of Differentiation Proteins | 1 | 2014 | 28 | 0.120 |
Why?
|
Signal Transduction | 5 | 2019 | 1908 | 0.120 |
Why?
|
Nerve Tissue Proteins | 1 | 2016 | 360 | 0.110 |
Why?
|
Sequence Homology, Amino Acid | 3 | 2004 | 269 | 0.110 |
Why?
|
Oxidative Stress | 1 | 2019 | 938 | 0.110 |
Why?
|
Testosterone | 1 | 2014 | 193 | 0.110 |
Why?
|
Drosophila | 2 | 2008 | 144 | 0.110 |
Why?
|
Up-Regulation | 4 | 2017 | 513 | 0.100 |
Why?
|
Gene Expression | 2 | 2014 | 674 | 0.100 |
Why?
|
Sound | 1 | 2012 | 7 | 0.100 |
Why?
|
Lung Neoplasms | 1 | 2016 | 358 | 0.100 |
Why?
|
Histones | 3 | 2011 | 190 | 0.100 |
Why?
|
Cell Separation | 1 | 2011 | 93 | 0.100 |
Why?
|
Apoptosis | 4 | 2023 | 1398 | 0.100 |
Why?
|
Green Fluorescent Proteins | 1 | 2012 | 208 | 0.100 |
Why?
|
Sulfoglycosphingolipids | 1 | 2010 | 1 | 0.090 |
Why?
|
Phenotype | 2 | 2011 | 689 | 0.090 |
Why?
|
Adenocarcinoma, Papillary | 1 | 2009 | 3 | 0.090 |
Why?
|
Frozen Sections | 1 | 2009 | 7 | 0.090 |
Why?
|
Microdissection | 1 | 2009 | 11 | 0.090 |
Why?
|
Adult Stem Cells | 1 | 2009 | 12 | 0.090 |
Why?
|
Lasers | 1 | 2009 | 65 | 0.090 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2009 | 11 | 0.090 |
Why?
|
Cell Differentiation | 2 | 2011 | 587 | 0.090 |
Why?
|
Ovarian Diseases | 1 | 2008 | 3 | 0.080 |
Why?
|
Mass Spectrometry | 1 | 2010 | 260 | 0.080 |
Why?
|
Mice | 5 | 2023 | 5913 | 0.080 |
Why?
|
Microspheres | 1 | 2009 | 49 | 0.080 |
Why?
|
Lipids | 1 | 2010 | 235 | 0.080 |
Why?
|
DNA | 1 | 2012 | 574 | 0.080 |
Why?
|
Leukemia, T-Cell | 1 | 2008 | 5 | 0.080 |
Why?
|
Dosage Compensation, Genetic | 1 | 2008 | 8 | 0.080 |
Why?
|
Embryonic Stem Cells | 1 | 2009 | 59 | 0.080 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2009 | 172 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 623 | 0.080 |
Why?
|
Recombination, Genetic | 2 | 2010 | 93 | 0.080 |
Why?
|
Carcinoma | 1 | 2008 | 96 | 0.080 |
Why?
|
Breast Neoplasms | 2 | 2018 | 1502 | 0.080 |
Why?
|
Cluster Analysis | 3 | 2014 | 195 | 0.080 |
Why?
|
Sequence Alignment | 2 | 2009 | 265 | 0.080 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2016 | 306 | 0.070 |
Why?
|
Genes, p53 | 1 | 2007 | 25 | 0.070 |
Why?
|
Cell Survival | 3 | 2019 | 864 | 0.070 |
Why?
|
Genes, Neoplasm | 1 | 2007 | 13 | 0.070 |
Why?
|
Multigene Family | 2 | 2010 | 106 | 0.070 |
Why?
|
Male | 7 | 2023 | 20025 | 0.070 |
Why?
|
Pan troglodytes | 1 | 2006 | 21 | 0.070 |
Why?
|
RNA, Small Interfering | 2 | 2019 | 409 | 0.070 |
Why?
|
Proteomics | 2 | 2019 | 325 | 0.070 |
Why?
|
MicroRNAs | 1 | 2011 | 426 | 0.070 |
Why?
|
Chromosome Mapping | 2 | 2003 | 188 | 0.060 |
Why?
|
Methyl-CpG-Binding Protein 2 | 1 | 2004 | 7 | 0.060 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2004 | 1 | 0.060 |
Why?
|
Genes, Insect | 1 | 2004 | 26 | 0.060 |
Why?
|
Mice, Nude | 2 | 2016 | 337 | 0.060 |
Why?
|
Immunohistochemistry | 1 | 2006 | 893 | 0.060 |
Why?
|
Sexual Behavior, Animal | 1 | 2004 | 53 | 0.060 |
Why?
|
Genomics | 1 | 2006 | 223 | 0.060 |
Why?
|
Conserved Sequence | 1 | 2004 | 119 | 0.060 |
Why?
|
Databases, Nucleic Acid | 1 | 2004 | 27 | 0.060 |
Why?
|
Macromolecular Substances | 1 | 2004 | 96 | 0.060 |
Why?
|
Amino Acid Substitution | 1 | 2004 | 132 | 0.060 |
Why?
|
Chromosomes, Fungal | 1 | 2003 | 3 | 0.060 |
Why?
|
Models, Genetic | 2 | 2006 | 172 | 0.060 |
Why?
|
Antineoplastic Agents | 2 | 2011 | 803 | 0.060 |
Why?
|
Mutagenesis, Insertional | 1 | 2003 | 32 | 0.060 |
Why?
|
Autoantigens | 1 | 2004 | 81 | 0.060 |
Why?
|
Protein Isoforms | 1 | 2004 | 130 | 0.060 |
Why?
|
Gene Expression Regulation | 3 | 2009 | 1015 | 0.060 |
Why?
|
Alleles | 1 | 2004 | 321 | 0.060 |
Why?
|
Protein Structure, Tertiary | 1 | 2004 | 408 | 0.050 |
Why?
|
Trans-Activators | 1 | 2004 | 174 | 0.050 |
Why?
|
Ribonuclease H | 1 | 2002 | 11 | 0.050 |
Why?
|
Genes | 1 | 2002 | 60 | 0.050 |
Why?
|
DNA, Intergenic | 1 | 2002 | 10 | 0.050 |
Why?
|
Cell Movement | 2 | 2019 | 571 | 0.050 |
Why?
|
Immune System | 1 | 2002 | 41 | 0.050 |
Why?
|
Drosophila Proteins | 1 | 2004 | 171 | 0.050 |
Why?
|
Reproduction | 1 | 2002 | 71 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2004 | 305 | 0.050 |
Why?
|
Mice, Inbred C57BL | 2 | 2017 | 1609 | 0.050 |
Why?
|
Neoplasm Staging | 2 | 2014 | 275 | 0.050 |
Why?
|
Cell Nucleus | 1 | 2002 | 366 | 0.050 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 1999 | 18 | 0.040 |
Why?
|
Gene Products, env | 1 | 1999 | 23 | 0.040 |
Why?
|
Gluconeogenesis | 1 | 2019 | 10 | 0.040 |
Why?
|
Disease Progression | 2 | 2015 | 601 | 0.040 |
Why?
|
Cells, Cultured | 2 | 2017 | 1518 | 0.040 |
Why?
|
Middle Aged | 4 | 2018 | 10129 | 0.040 |
Why?
|
Prognosis | 2 | 2014 | 739 | 0.040 |
Why?
|
Aged | 3 | 2018 | 6741 | 0.040 |
Why?
|
Microarray Analysis | 1 | 2019 | 61 | 0.040 |
Why?
|
Metabolomics | 1 | 2019 | 81 | 0.040 |
Why?
|
Cadherins | 1 | 2018 | 90 | 0.040 |
Why?
|
Antimetabolites, Antineoplastic | 2 | 2008 | 20 | 0.040 |
Why?
|
Base Sequence | 3 | 2009 | 997 | 0.040 |
Why?
|
Pyruvic Acid | 1 | 2017 | 18 | 0.040 |
Why?
|
Cell Line | 2 | 2011 | 1354 | 0.040 |
Why?
|
Breast | 1 | 2018 | 135 | 0.040 |
Why?
|
Epigenesis, Genetic | 2 | 2011 | 219 | 0.040 |
Why?
|
Antigen Presentation | 1 | 2017 | 54 | 0.040 |
Why?
|
Cell Membrane Permeability | 1 | 2017 | 52 | 0.040 |
Why?
|
Prostate | 1 | 2018 | 154 | 0.040 |
Why?
|
Interleukin-10 | 1 | 2017 | 75 | 0.040 |
Why?
|
Enhancer Elements, Genetic | 1 | 1997 | 62 | 0.040 |
Why?
|
Receptor, erbB-3 | 1 | 2016 | 12 | 0.030 |
Why?
|
Immunity, Innate | 1 | 2017 | 149 | 0.030 |
Why?
|
Transcription, Genetic | 1 | 2019 | 578 | 0.030 |
Why?
|
Aneuploidy | 1 | 2015 | 23 | 0.030 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2015 | 32 | 0.030 |
Why?
|
Adult | 3 | 2018 | 11712 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2016 | 259 | 0.030 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2015 | 28 | 0.030 |
Why?
|
Receptor, erbB-2 | 1 | 2016 | 133 | 0.030 |
Why?
|
Genetic Loci | 1 | 2015 | 90 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2016 | 197 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2014 | 122 | 0.030 |
Why?
|
Mice, Knockout | 1 | 2017 | 933 | 0.030 |
Why?
|
Disease-Free Survival | 1 | 2014 | 113 | 0.030 |
Why?
|
Tumor Burden | 1 | 2014 | 77 | 0.030 |
Why?
|
Down-Regulation | 1 | 2016 | 435 | 0.030 |
Why?
|
Microtubules | 1 | 2015 | 120 | 0.030 |
Why?
|
Receptors, Androgen | 1 | 2015 | 126 | 0.030 |
Why?
|
Protein Interaction Mapping | 1 | 2014 | 61 | 0.030 |
Why?
|
Hela Cells | 1 | 2015 | 366 | 0.030 |
Why?
|
Mitochondria | 1 | 2017 | 487 | 0.030 |
Why?
|
Mitosis | 1 | 2014 | 99 | 0.030 |
Why?
|
Lung | 1 | 2016 | 446 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2018 | 2379 | 0.030 |
Why?
|
Ultrasonic Therapy | 1 | 2012 | 4 | 0.030 |
Why?
|
Neoplasms | 1 | 2002 | 1103 | 0.030 |
Why?
|
DNA Topoisomerases, Type II | 1 | 2012 | 10 | 0.030 |
Why?
|
Methods | 1 | 2011 | 13 | 0.030 |
Why?
|
Erythroid Precursor Cells | 1 | 2011 | 7 | 0.030 |
Why?
|
K562 Cells | 1 | 2011 | 32 | 0.030 |
Why?
|
Spheroids, Cellular | 1 | 2011 | 28 | 0.030 |
Why?
|
Antigens, Neoplasm | 1 | 2012 | 59 | 0.020 |
Why?
|
Plasmids | 1 | 2012 | 246 | 0.020 |
Why?
|
Age Factors | 1 | 2014 | 1033 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2011 | 251 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2016 | 1371 | 0.020 |
Why?
|
Pharmaceutical Preparations | 1 | 2012 | 75 | 0.020 |
Why?
|
DNA, Plant | 1 | 2010 | 13 | 0.020 |
Why?
|
Genome, Plant | 1 | 2010 | 27 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2011 | 222 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2012 | 307 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2012 | 229 | 0.020 |
Why?
|
Burkitt Lymphoma | 1 | 2009 | 23 | 0.020 |
Why?
|
Genome-Wide Association Study | 1 | 2011 | 333 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2008 | 67 | 0.020 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2009 | 142 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2011 | 1039 | 0.020 |
Why?
|
Tretinoin | 1 | 2009 | 50 | 0.020 |
Why?
|
Histone Acetyltransferases | 1 | 2008 | 19 | 0.020 |
Why?
|
Jurkat Cells | 1 | 2008 | 79 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2008 | 217 | 0.020 |
Why?
|
Models, Statistical | 1 | 2009 | 180 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2008 | 76 | 0.020 |
Why?
|
Animals, Genetically Modified | 1 | 2008 | 99 | 0.020 |
Why?
|
Survival Analysis | 1 | 2008 | 325 | 0.020 |
Why?
|
Binding Sites | 1 | 2009 | 651 | 0.020 |
Why?
|
Loss of Heterozygosity | 1 | 2007 | 19 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2008 | 168 | 0.020 |
Why?
|
Azacitidine | 1 | 2007 | 22 | 0.020 |
Why?
|
Drug Design | 1 | 2008 | 162 | 0.020 |
Why?
|
CpG Islands | 1 | 2007 | 97 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2011 | 1207 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2008 | 974 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2007 | 217 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2008 | 935 | 0.020 |
Why?
|
Cohort Studies | 1 | 2008 | 1492 | 0.020 |
Why?
|
Genetic Complementation Test | 1 | 2002 | 59 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2002 | 90 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2008 | 2026 | 0.010 |
Why?
|
Databases, Genetic | 1 | 2002 | 93 | 0.010 |
Why?
|
Genetic Code | 1 | 1997 | 7 | 0.010 |
Why?
|